BMEZ vs. HELX

Last updated Apr 2, 2026

Compare and contrast key facts about BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX).

HELX is an actively managed fund by Franklin Templeton. It was launched on Feb 25, 2020.

Performance

BMEZ vs. HELX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX). The values are adjusted to include any dividend payments, if applicable.

BMEZ vs. HELX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
BMEZ BlackRock Health Sciences Trust II	-1.47%	18.69%	9.54%	5.07%	-32.65%	-6.00%	46.15%
HELX Franklin Genomic Advancements ETF	-8.14%	26.34%	-5.32%	1.14%	-37.89%	9.80%	85.05%

Returns By Period

In the year-to-date period, BMEZ achieves a -1.47% return, which is significantly higher than HELX's -8.14% return.

BMEZ

• 1D: 0.97%
• 1M: -2.45%
• YTD: -1.47%
• 6M: 3.68%
• 1Y: 11.42%
• 3Y*: 6.55%
• 5Y*: -2.37%
• 10Y*: —

HELX

• 1D: 0.90%
• 1M: -2.17%
• YTD: -8.14%
• 6M: 5.21%
• 1Y: 26.31%
• 3Y*: 3.29%
• 5Y*: -5.21%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

BMEZ vs. HELX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BMEZ

BMEZ Risk / Return Rank: 59
BMEZ Sharpe Ratio Rank: 63
BMEZ Sortino Ratio Rank: 54
BMEZ Omega Ratio Rank: 53
BMEZ Calmar Ratio Rank: 60
BMEZ Martin Ratio Rank: 63

HELX

HELX Risk / Return Rank: 53
HELX Sharpe Ratio Rank: 60
HELX Sortino Ratio Rank: 61
HELX Omega Ratio Rank: 53
HELX Calmar Ratio Rank: 47
HELX Martin Ratio Rank: 43

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BMEZ vs. HELX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Trust II (BMEZ) and Franklin Genomic Advancements ETF (HELX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BMEZ	HELX	Difference
Sharpe ratio Return per unit of total volatility	0.63	1.10	-0.47
Sortino ratio Return per unit of downside risk	1.00	1.63	-0.63
Omega ratio Gain probability vs. loss probability	1.13	1.21	-0.08
Calmar ratio Return relative to maximum drawdown	0.82	1.33	-0.52
Martin ratio Return relative to average drawdown	2.42	4.32	-1.89
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BMEZ vs. HELX - Sharpe Ratio Comparison

The current BMEZ Sharpe Ratio is 0.63, which is lower than the HELX Sharpe Ratio of 1.10. The chart below compares the historical Sharpe Ratios of BMEZ and HELX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	BMEZ	HELX	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.63	1.10	-0.47
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.12	-0.22	+0.10
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.21	-0.05

Correlation

The correlation between BMEZ and HELX is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Dividends

BMEZ vs. HELX - Dividend Comparison

BMEZ's dividend yield for the trailing twelve months is around 11.51%, more than HELX's 0.43% yield.

	TTM	2025	2024	2023	2022	2021	2020
BMEZ BlackRock Health Sciences Trust II	11.51%	12.43%	11.74%	10.80%	11.28%	6.51%	3.14%
HELX Franklin Genomic Advancements ETF	0.43%	0.39%	0.00%	0.00%	0.00%	0.24%	0.12%

Drawdowns

BMEZ vs. HELX - Drawdown Comparison

The maximum BMEZ drawdown since its inception was -46.19%, smaller than the maximum HELX drawdown of -58.75%. Use the drawdown chart below to compare losses from any high point for BMEZ and HELX.

Drawdown Indicators

	BMEZ	HELX	Difference
Max Drawdown Largest peak-to-trough decline	-46.19%	-58.75%	+12.56%
Max Drawdown (1Y) Largest decline over 1 year	-11.24%	-18.01%	+6.77%
Max Drawdown (5Y) Largest decline over 5 years	-46.17%	-58.75%	+12.58%
Current Drawdown Current decline from peak	-20.96%	-42.36%	+21.40%
Average Drawdown Average peak-to-trough decline	-24.24%	-34.12%	+9.88%
Ulcer Index Depth and duration of drawdowns from previous peaks	3.79%	5.56%	-1.77%

Volatility

BMEZ vs. HELX - Volatility Comparison

The current volatility for BlackRock Health Sciences Trust II (BMEZ) is 6.65%, while Franklin Genomic Advancements ETF (HELX) has a volatility of 8.75%. This indicates that BMEZ experiences smaller price fluctuations and is considered to be less risky than HELX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BMEZ	HELX	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.65%	8.75%	-2.10%
Volatility (6M) Calculated over the trailing 6-month period	11.48%	15.40%	-3.92%
Volatility (1Y) Calculated over the trailing 1-year period	18.46%	24.21%	-5.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	20.06%	24.26%	-4.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	24.35%	27.46%	-3.11%